PROCEPT BioRobotics Corporation Common Stock

PRCTNASDAQUSD
27.23 USD
0.23 (0.84%)🟢LIVE (AS OF 11:55 AM EDT)
🟢Market: OPEN
Open?$27.04
High?$27.47
Low?$26.65
Prev. Close?$27.00
Volume?191.5K
Avg. Volume?1.5M
VWAP?$26.97
Rel. Volume?0.13x
Bid / Ask
Bid?$27.09 × 100
Ask?$27.16 × 100
Spread?$0.07
Midpoint?$27.13
Valuation & Ratios
Market Cap?1.5B
Shares Out?56.9M
Float?54.7M
Float %?96.9%
P/E Ratio?N/A
P/B Ratio?4.42
EPS?-$1.80
Dividend?0.00%
Ex-Dividend?N/A

PRCT is currently priced at $27.23. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, PRCT trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Employees
888
Market Cap
1.5B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-09-15
Address
150 BAYTECH DRIVE
SAN JOSE, CA 95134
Phone: (650) 232-9832
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
99
Momentum?
40
Short Sent.?
55
Piotroski F-Score?2/9Weak
Altman Z-Score?5.50Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.29%High
Short Interest?6.7M
Days to Cover?4.0
Free Float54.7M
Avg Daily Volume1.7M
Settlement Date2026-05-15
Financial Health
Current Ratio?6.73Strong
Quick Ratio?5.51Strong
Cash Ratio?3.86Strong
Debt/Equity?0.15Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A
P/B?
Peers
100
S&P
41
4.42FAIR
P/S?
Peers
100
S&P
31
4.77FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-13.1CHEAP
EV/Sales?
Peers
100
S&P
45
4.17FAIR
Returns & Efficiency
ROE?
S&P
6
-29.5%WEAK
ROA?
S&P
3
-21.0%WEAK
Cash Flow & Enterprise
FCF?$-80566000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day